Pituitary Disorders Education & Support
HomeAbout The PDESContact UsDonationsMembershipOur SponsorsSurveys

Smile
Glossary Of TermsClinical TrialsHelpful LinksWellness CenterMessage Board
Pituitary Conditions and TreatmentsPatient & Physician SeminarsPituitary DisordersNewsletterTreatment Centers and ResourcesHormone DeficienciesPatient Stories

Pituitary Conditions & Treatments
Pituitary InformationDiagnosis & TreatmentSurgery & RadiationNew Treatments

Novartis drug Signifor® recommended by FDA advisory committee for approval to treat patients with Cushing's disease

 

Modified-release hydrocortisone (Plenadren) launched for adrenal insufficiency

 

Sandostatin® LAR Depot:A Long History of Control in Acromegaly

 

# # #

 

Top

 
 



The use of this web site is not a substitute for medical, legal, or other professional services.
Consult a competent professional for answers to your specific questions.

Home | About The PDES | Contact Us | Membership | Our Sponsors | Surveys | News | Glossary Of Terms
Helpful Links | Wellness Center | Message Board | Pituitary Conditions & Treatments
Patient & Physician Seminars | Treatment Centers & Resources | Patient Stories | Site Map

Pituitary Disorders Education & Support ©2004, All Rights Reserved.

Web site Design and development Design Studio 352